agalsidase beta (fabrazyme) Report issue

Biologics Recombinant protein Orphan Drug FDA Approved FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Alpha-galactosidase is a glycoside hydrolase enzyme that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. Glycosidase is an important class of enzyme catalyzing many catabolic processes, including cleaving glycoproteins and glycolipids, and polysaccharides. Specifically, α-GAL catalyzes the removal of the terminal α-galactose from oligosaccharides.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$661.0100 - $6004.7700
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

agalsidase | agalsidase beta | agalsidase beta (genetical recombination) | alpha-d-galactopyranosidase | alpha-d-galactosidase | alpha-d-galactosidase a | alpha-d- galactoside galactohydrolase | alpha-galactisidase | alpha-galactosidase | alpha-galactosidase a | alpha-galactosidase a precursor | ec 3.2.1.22 | fabrazyme | gc1119 | melibiase | recombinant human alpha-galactosidase

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue